Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of opioid misuse with anxiety and depression: A systematic review of the literature
Andrew H. Rogers, Michael J. Zvolensky, Joseph W. Ditre, et al.
Clinical Psychology Review (2021) Vol. 84, pp. 101978-101978
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis
Thomas Santo, Gabrielle Campbell, Natasa Gisev, et al.
Drug and Alcohol Dependence (2022) Vol. 238, pp. 109551-109551
Open Access | Times Cited: 85
Sex disparities in outcome of medication-assisted therapy of opioid use disorder: Nationally representative outpatient clinic data
Eduardo R. Butelman, Yuefeng Huang, A.H. Mcfarlane, et al.
Drug and Alcohol Dependence (2025) Vol. 267, pp. 112535-112535
Closed Access | Times Cited: 2
Mindfulness-Oriented Recovery Enhancement for Addictive Behavior, Psychiatric Distress, and Chronic Pain: A Multilevel Meta-Analysis of Randomized Controlled Trials
Anna Parisi, R. Lynae Roberts, Adam W. Hanley, et al.
Mindfulness (2022) Vol. 13, Iss. 10, pp. 2396-2412
Open Access | Times Cited: 39
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 33
Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids
Ajda Bedene, Albert Dahan, Frits R. Rosendaal, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 9, pp. 1081-1094
Open Access | Times Cited: 25
Characteristics and Risk of Adverse Mental Health Events Amongst Users of the National Overdose Response Service (NORS) Telephone Hotline
Dylan Viste, William Rioux, Nathan Rider, et al.
International Journal of Mental Health and Addiction (2024)
Open Access | Times Cited: 5
Addressing long overdue social and structural determinants of the opioid epidemic
Nabila El‐Bassel, Steven Shoptaw, David Goodman‐Meza, et al.
Drug and Alcohol Dependence (2021) Vol. 222, pp. 108679-108679
Closed Access | Times Cited: 31
Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders
Amy Hauck Newman, Zheng‐Xiong Xi, Christian Heidbreder
Current topics in behavioral neurosciences (2022), pp. 157-201
Open Access | Times Cited: 22
Mood and Anxiety Symptoms in Persons Taking Prescription Opioids: A Systematic Review with Meta-Analyses of Longitudinal Studies
Janni Leung, Thomas Santo, Samantha Colledge‐Frisby, et al.
Pain Medicine (2022) Vol. 23, Iss. 8, pp. 1442-1456
Open Access | Times Cited: 20
Depression and anxiety symptoms in adolescents and young adults in Greece: Prevalence and associated factors
Maria Basta, Katerina Micheli, Katerina Koutra, et al.
Journal of Affective Disorders Reports (2022) Vol. 8, pp. 100334-100334
Open Access | Times Cited: 20
Nationally Representative Rates of Incident Prescription Opioid Use Among United States Adults and Selected Subpopulations: Longitudinal Cohort Study from the National Health Interview Survey, 2019-2020
Ryan S. D’Souza, Richard L. Nahin
Journal of Pain (2024), pp. 104665-104665
Open Access | Times Cited: 4
Anxiety-like behavior during protracted morphine withdrawal is driven by gut microbial dysbiosis and attenuated with probiotic treatment
Mark Oppenheimer, Junyi Tao, Shamsudheen Moidunny, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Sex differences in opioid misuse among adults with chronic lower back pain: the roles of negative affect and related transdiagnostic factors
Julia D. Buckner, Caroline R. Scherzer, Luke A. Vargo, et al.
Journal of Substance Use (2025), pp. 1-7
Closed Access
Pre-Arrest Diversion-To-Treatment for Adults with Substance Use Disorder: Health Outcomes and Predictors of Program Completion
Alice Zhang, Jennifer E. Nyland, Joseph A. Balles, et al.
Justice Evaluation Journal (2025), pp. 1-18
Open Access
Illicit Prescription Opioid Use Among U.S. Firefighters
Richard R. Suminski, Sara A. Jahnke, Nattinee Jitnarin, et al.
Fire (2025) Vol. 8, Iss. 3, pp. 112-112
Open Access
Association of SOD1 rs36232792 with opioid use disorder and a novel PCR-RFLP method for SOD2 rs5746136
Seval Küçükparmaksız, Dilek Kaya-Akyüzlü, Selin Özkan-Kotiloğlu, et al.
Pharmacogenomics (2025), pp. 1-11
Closed Access
Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
Arash Mansoori, Amir Bazrafshan, Jamshid Ahmadi, et al.
Trials (2025) Vol. 26, Iss. 1
Open Access
Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review
Mary R. Shen, D Campbell, A Kopczyński, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
The Internet addiction test: Psychometric properties, socio-demographic risk factors and addictive co-morbidities in a large adult sample
Yaron Sela, Ruth Lev Bar‐Or, Ariel Kor, et al.
Addictive Behaviors (2021) Vol. 122, pp. 107023-107023
Closed Access | Times Cited: 16
Minocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users
Shanthi Mogali, Paula Askalsky, Gabriela Madera, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 209, pp. 173241-173241
Open Access | Times Cited: 16
Neurophysiological Deficits During Reappraisal of Negative Emotional Stimuli in Opioid Misuse
Justin Hudak, Edward M. Bernat, Spencer T. Fix, et al.
Biological Psychiatry (2022) Vol. 91, Iss. 12, pp. 1070-1078
Open Access | Times Cited: 12
The relationship between sleep profiles and anxiety and depression in addicted patients: A latent profile analysis
Zhaoyang Xie, Zheng Dai, Yicheng Wei, et al.
Sleep Medicine (2024) Vol. 122, pp. 192-197
Closed Access | Times Cited: 2
Multidisciplinary Strategies for Preventing Opioid Misuse and Escalation by Targeting Mental Health Symptoms and Conditions
Amy M. Yule, Claudia-Santi F. Fernandes, Elizabeth A. Stormshak, et al.
Prevention Science (2023) Vol. 24, Iss. S1, pp. 77-87
Open Access | Times Cited: 6
Opioid coping motives and pain intensity among adults with chronic low back pain: associations with mood, pain reactivity, and opioid misuse
Andrew H. Rogers, Luke F. Heggeness, Tanya Smit, et al.
Journal of Behavioral Medicine (2023)
Closed Access | Times Cited: 5
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial
Gabriel Bastien, Christina McAnulty, Omar Ledjiar, et al.
The Canadian Journal of Psychiatry (2022) Vol. 68, Iss. 8, pp. 572-585
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top